Correvio Pharma Corp.(Toronto Stock Exchange : CRME)
(
)
CRME After-Hours:
()
as of PM
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Message Boards
...
News
...
Health Technology » Biotechnology
Company Profile
Cardiome Pharma Corp. is a specialty biopharmaceutical company dedicated to the discovery, development and commercialization of new therapies that will improve the health of patients suffering from heart disease around the world. Cardiome has one marketed product, BRINAVESSTM (vernakalant IV), approved in Europe and other territories for the rapid conversion of recent onset atrial fibrillation to sinus rhythm in adults.